The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients
- 1 September 1990
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 19 (3) , 619-626
- https://doi.org/10.1016/0360-3016(90)90488-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasmsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomasInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Monoclonal antibodies to phosphotyrosineJournal of Immunological Methods, 1988
- Apparent role of the macrophage growth factor, CSF-1, in placental developmentNature, 1987
- Colony‐stimulating factor‐1 induces thromboplastin activity in murine macrophages and human monocytesJournal of Cellular Physiology, 1987
- The Human Hematopoietic Colony-Stimulating FactorsScience, 1987
- Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines.Journal of Clinical Investigation, 1986
- Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminusNature, 1986
- Characterization of the human c-fms gene product and its expression in cells of the monocyte-macrophage lineage.Molecular and Cellular Biology, 1985
- Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probesCell, 1980